Theme and Background
This chapter uses the acquisition of TRW Automotive Holdings by ZF Friedrichshafen at $105.60 per share as a case study to explore the widespread phenomenon of "merger objection lawsuits" in current M&A transactions. The report notes that less than 10% of acquisitions were sued a decade ago, whereas today nearly every deal triggers multiple lawsuits, yet the vast majority yield zero benefit for shareholders and only profit law firms. The core of the article is to demonstrate how Oakmark, as a long-term value investor, rationally evaluates the reasonableness of acquisition proposals.
Core Thesis
The author’s core investment argument is: M&A is an important avenue for value realization and should be actively welcomed rather than blindly opposed. Counterintuitive judgments include:
- Despite the proliferation of mostly baseless merger objection lawsuits, the author acknowledges that management may face conflicts of interest, thus requiring a systematic evaluation of acquisition proposals.
- An acquisition price slightly below valuation ($105.60 vs. $109) does not constitute grounds for rejection. As long as the process is transparent and management incentives align with shareholders, accepting the deal and reallocating capital is the superior choice.
Key Arguments and Data
- TRW Investment Journey: Purchased at $32 in late 2011, with the author’s valuation at approximately $63 (reasonable range $57–$70). Over three years of holding, TRW accumulated earnings per share of about $20, and the valuation rose to $109. Although the acquisition price of $105.60 was slightly below the valuation, it remained within the 10% margin of error.
- Management Incentives: Management and directors held over $500 million in TRW stock (at the acquisition price). Every $1 increase in the stock price would personally benefit them by more than $5 million, aligning their interests closely with shareholders.
- Process Transparency: On July 10, 2014, Bloomberg reported ZF’s bid at $95–$103. TRW publicly confirmed this and invited other bidders. Nine weeks later, the deal closed at $105.60, above the upper end of the rumored range, indicating a premium was secured during negotiations.
- Historical Comparison: Over the past decade, merger objection lawsuits have risen from less than 10% of transactions to nearly every deal facing multiple lawsuits.
Comparative Data Table:
| Metric |
At Purchase in Late 2011 |
At End of 2013 |
At Acquisition in September 2014 |
| Stock Price |
$32 |
$74 |
$105.60 |
| Author’s Valuation |
$63 (range $57–$70) |
Not specified |
$109 |
| Cumulative EPS |
- |
- |
Approximately $20 |
Companies/Assets Involved
- TRW Automotive Holdings: Core case, acquired by ZF at $105.60/share. The author is bullish, viewing the deal as reasonable.
- ZF Friedrichshafen: Acquirer, raising its bid from the rumored $95–$103 to $105.60.
- DirecTV: Acquired by AT&T, benefiting Oakmark.
- Forest Laboratories: Acquired by Actavis, benefiting Oakmark.
- Covidien: Merged with Medtronic, with the stock price rising from $72 to $92; held by Oakmark.
- AT&T, Actavis, Medtronic: Acquirers, not directly analyzed.
- Oakmark Fund Holdings: As of September 30, 2014, Covidien accounted for 0.1%, Medtronic for 1.7%, with the rest already liquidated.
Investment Insights
- For investors holding shares in an acquired company: Do not blindly oppose the acquisition; instead, systematically evaluate: 1) whether management’s stock holdings are large enough to align their interests with shareholders; 2) whether the acquisition process is transparent and allows for other bidders. If both conditions are met, even if the acquisition price is slightly below valuation, accepting the deal and reinvesting in more undervalued assets is a rational choice.
- On merger objection lawsuits: The vast majority provide zero value to shareholders, but investors must still remain vigilant about potential management conflicts of interest. Quantifying management incentives through public documents (e.g., proxy statements, 10-Ks) is key to identifying genuine risks.
- Valuation methodology: Use comparable acquisition prices, discounted cash flow, and historical valuation methods, accepting a 10% margin of error to avoid false precision.
Theme and Background
This section primarily discloses the holdings of the Oakmark Select Fund as of September 30, 2014, and reiterates the fund's investment strategy and risk characteristics. The report emphasizes that the fund employs a concentrated holdings strategy and is a non-diversified fund, meaning individual stock fluctuations have a greater impact on net asset value.
Core Views
- The fund's holdings are highly concentrated, so individual stock gains or losses have a significantly larger impact on the fund's net asset value compared to diversified funds.
- The non-diversified structure (Oakmark Select Fund) amplifies portfolio volatility but may deliver higher returns over the long term.
- Mid-cap stocks typically exhibit higher volatility than large-cap stocks and may underperform small-cap and large-cap stocks during certain periods.
Key Arguments and Data
- Holdings Concentration: TRW Automotive Holdings accounted for 4.2% of the Oakmark Select Fund's net assets, Medtronic accounted for 3.5%, while the other mentioned companies (ZF Friedrichshafen, AT&T, DIRECTV, Actavis, Forest Laboratories, Covidien) had a 0% weighting.
- Volatility Risk: Because the fund invests in a relatively small number of stocks, the rise or fall of a single security has a greater impact on the fund's net asset value. The performance volatility of the non-diversified fund (Oakmark Select Fund) is higher than that of diversified funds.
- Scale Effect: Mid-cap stocks generally exhibit higher volatility than large-cap stocks and may underperform small-cap and large-cap stocks during certain periods.
Companies/Assets Involved
| Company/Asset |
Weighting (Oakmark Select Fund) |
Role/Description |
| TRW Automotive Holdings Corp. |
4.2% |
Core holding of the fund, in the auto parts industry |
| Medtronic, Inc. |
3.5% |
Core holding of the fund, in the medical device industry |
| ZF Friedrichshafen AG |
0% |
Not held, but mentioned as the acquirer in a prior context |
| AT&T Corp. |
0% |
Not held |
| DIRECTV |
0% |
Not held |
| Actavis PLC |
0% |
Not held |
| Forest Laboratories, Inc. |
0% |
Not held |
| Covidien PLC |
0% |
Not held |
Investment Insights
- Investors should fully understand the high volatility risk associated with concentrated holdings and non-diversified strategies. Such funds are more suitable for investors with a higher risk tolerance and a pursuit of long-term excess returns.
- Pay attention to industry dynamics and fundamental changes in the fund's core holdings (e.g., TRW, Medtronic), as they have a significant weight in influencing the fund's net asset value.
- The risk-return profile of mid-cap stocks differs from that of large-cap stocks. Investors should adjust their portfolio allocations based on their own size exposure.